c-LEcta GmbH
Yury Alexandra Pedraza Ramirez is an experienced professional in the fields of auditing, risk management, and data protection. Currently serving as an Auditoria Interna at Casalimpia S.A. since May 2024, Yury has previously held roles in various companies including Elanco as Purches to Pay from May 2022 to May 2024, and as a Senior Risk and Compliance Auditor at Banco Pichincha from December 2016 to October 2017. Yury's background includes positions in assurance at Baker Tilly en Colombia and Ernst & Young, as well as a role as Coordinadora General at 40 Days For Life. Educational qualifications include a Diplomado de Gestion de Riesgos Financieros from Universidad del Rosario, and ongoing studies in Human Resource Management at Politécnico Grancolombiano, alongside a degree in Contaduria Publica from Universidad Cooperativa de Colombia.
This person is not in any offices
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.